[{"id":"4e48c401-87aa-4941-b08c-b08ad8a89261","acronym":"","url":"https://clinicaltrials.gov/study/NCT03768310","created_at":"2021-01-18T18:38:42.443Z","updated_at":"2024-07-02T16:36:07.011Z","phase":"Phase 1","brief_title":"CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)","source_id_and_acronym":"NCT03768310","lead_sponsor":"Baylor College of Medicine","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19CAR/virus specific T cell therapy"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 06/01/2022","start_date":" 06/01/2022","primary_txt":" Primary completion: 08/01/2025","primary_completion_date":" 08/01/2025","study_txt":" Completion: 08/01/2040","study_completion_date":" 08/01/2040","last_update_posted":"2022-07-21"}]